Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rallybio Corp | 926,352 | reported | 19 May 2026 | tx 14+302,473 |
| InMed Pharmaceuticals Inc. | 400,000 | reported | 19 May 2026 | tx 3+468,551 |
| PALVELLA THERAPEUTICS, INC. | 129,574 | reported | 12 Aug 2024 | tx 3+6,000 |
| Keros Therapeutics, Inc. | 0 | reported | 16 May 2025 | tx 3−1,314 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | PURCHASE | InMed Pharmaceuticals Inc. | 68,551 | 1.60 USD | |
| 19 May 2026 | PURCHASE | InMed Pharmaceuticals Inc. | 200,000 | 1.56 USD | |
| 19 May 2026 | PURCHASE | InMed Pharmaceuticals Inc. | 200,000 | 1.50 USD | |
| 18 May 2026 | PURCHASE | Rallybio Corp | 6,009 | 13.98 USD | |
| 19 May 2026 | PURCHASE | Rallybio Corp | 10,000 | 13.98 USD | |
| 19 May 2026 | PURCHASE | Rallybio Corp | 200 | 13.80 USD | |
| 13 May 2026 | PURCHASE | Rallybio Corp | 4,081 | 13.80 USD | |
| 13 May 2026 | PURCHASE | Rallybio Corp | 75,178 | 14.00 USD | |
| 15 May 2026 | PURCHASE | Rallybio Corp | 100 | 13.80 USD | |
| 15 May 2026 | PURCHASE | Rallybio Corp | 200 | 13.95 USD | |
| 11 May 2026 | PURCHASE | Rallybio Corp | 5,100 | 14.00 USD | |
| 11 May 2026 | PURCHASE | Rallybio Corp | 25,000 | 14.00 USD | |
| 11 May 2026 | PURCHASE | Rallybio Corp | 19,900 | 14.00 USD | |
| 12 May 2026 | PURCHASE | Rallybio Corp | 800 | 13.83 USD | |
| 04 May 2026 | PURCHASE | Rallybio Corp | 3,900 | 13.90 USD | |
| 04 May 2026 | PURCHASE | Rallybio Corp | 116,904 | 13.97 USD | first after silence |
| 05 May 2026 | PURCHASE | Rallybio Corp | 35,101 | 14.00 USD | |
| 16 May 2025 | EXERCISE | Keros Therapeutics, Inc. | 836 | 0.00 USD | deriv |
| 16 May 2025 | EXERCISE | Keros Therapeutics, Inc. | 300 | 0.00 USD | deriv |
| 16 May 2025 | EXERCISE | Keros Therapeutics, Inc. | 178 | 0.00 USD | deriv |
| 09 Aug 2024 | PURCHASE | PALVELLA THERAPEUTICS, INC. | 3,000 | 14.89 USD | |
| 12 Aug 2024 | PURCHASE | PALVELLA THERAPEUTICS, INC. | 757 | 15.88 USD | |
| 12 Aug 2024 | PURCHASE | PALVELLA THERAPEUTICS, INC. | 2,243 | 15.88 USD |
1 purchase reported after at least 12 months of silence — most recent on 04 May 2026.